The TRANSCEND Cancer Initiative (TCI) is a TRANSlational researCh incubator for the trEatment, interceptioN, anD prevention of cancer.
TRANSCEND provides critical resources for translational research and networking opportunities for investigators in the division of surgery to facilitate high-impact translational research studies across disease-sites and to facilitate a team science network that will accelerate discoveries and innovation to treat, intercept, and ultimately prevent cancer.
The TCI facilitates interactions with existing platforms and institutes (Cancer Genomics Laboratory, Translational Molecular Pathology, Institute for Personalized Cancer Therapy, Immunotherapy Platform, Cancer Control and Prevention, Integrative Medicine, the Program for Innovative Microbiome and Translational Research – PRIME-TR, and others) and provides key resources to integrate and learn from diverse data sets (genomic and immune profiling, digital spatial profiling, among other cutting-edge profiling strategies). TCI also has shared resources for immune profiling and other analyses that are available to TCI investigators. The initiative works with investigators and Strategic Industry Ventures to maximize and translate insights gained, including industry-sponsored translational clinical trials.
The TRANSCEND Cancer Initiative is open for collaborations within the MD Anderson Surgical community. The TCI works with investigators to design and institute translational research studies, and to analyze samples from existing translational research efforts (such as from novel clinical trials, neoadjuvant / minimal residual disease (MRD) trials, institutional initiatives) with the goal of deriving novel targets to improve therapeutic responses for treatment in patients with cancer, and to develop strategies to intercept and ultimately prevent cancer altogether.
Please fill out the collaboration form and a member from our team will be in contact with you.
Christina L. Roland, M.D., M.S.
Travis T. Sims, M.D., M.P.H.
Jennifer Wargo, M.D., MMSc
TRANSCEND Cancer Initiative
Department of Surgical Oncology - Unit 1484
University of Texas M.D. Anderson Cancer Center
P.O. Box 301402
Houston, TX 77230-1402